
Manufacturing · BSE
Patel Chem Specialities Limited, established in 2008, is involved in the manufacturing and export of pharmaceutical excipients and specialty chemicals. These chemicals are essential in various industries such as pharmaceuticals, food, cosmetics, and industrial applications. They serve important roles like binding, thickening, stabilizing, gelling, and helping tablets break down properly. The company operates from two manufacturing units located in Vatva, Ahmedabad, and Talod, Himmatnagar. These facilities follow strict quality standards and hold certifications like US-DMF and GMP. Covering an area of 7,000 square yards, the facility has a production capacity of over 7,200 metric tons per year. It includes sections for storage, production, research and development, quality control, packaging, and warehousing. Patel Chem has expanded its presence across East Asia, Europe, the Middle East, North America, and Southeast Asia by delivering high-quality products that meet global standards. The company’s main products include Rheollose (used for thickening and stabilizing), Disolwell (a tablet disintegrant), Swellcal (another disintegrant), and AmyloTab (used to help tablets dissolve). As of November 30, 2024, the company has 109 employees.
Price Band
₹82 – ₹84
Issue Size
₹58.80 Cr
Lot Size
1600 shares
GMP
+32.1%
Est. Listing
₹111
at current GMP
Subscribed
167.37x
overall
Open
25 Jul 2025
Close
29 Jul 2025
Allotment
30 Jul 2025
Refund
31 Jul 2025
Demat Credit
1 Aug 2025
Listing
1 Aug 2025
Designated Registrar: Link Intime India Private Limited
Allotment Date
30 Jul 2025
Basis finalization
Refunds Initiate
31 Jul 2025
Mandate release
Demat Credit
1 Aug 2025
Shares in demat
Listing Debut
1 Aug 2025
Trading begins
Patel Chem Specialities Limited is bringing an initial public offering (IPO) in the Manufacturing sector with an aggregate issue size of ₹58.8 Crores. The shares are offered at a price band of ₹82 to ₹84 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,34,400 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-08-01, while un-allotted funds or UPI block mandates will be released on 2025-07-31.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.